Antibody-based therapeutics against components of the IGF system

The insulin-like growth factor I (IGF-I) receptor (IGF-1R) is overexpressed in most human neoplasms tested so far. Many tumors in young patients produce high levels of the IGF-1R ligands, IGF-I and IGF-II. Given the complexity of the IGF signaling pathway, its complete inhibition may require combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yang, Dimitrov, Dimiter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518512/
https://www.ncbi.nlm.nih.gov/pubmed/23243603
http://dx.doi.org/10.4161/onci.20925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518512/
https://www.ncbi.nlm.nih.gov/pubmed/23243603
http://dx.doi.org/10.4161/onci.20925

Ejemplares similares